152 results on '"Vissing J"'
Search Results
2. Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?
3. Exercise training in metabolic myopathies
4. 21088. RESPUESTA A ROZANOLIXIZUMAB A TRAVÉS DE CICLOS DE TRATAMIENTO EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA: UN ANÁLISIS POST HOC
5. 21248. EXPRESIÓN MÍNIMA DE LOS SÍNTOMAS (MSE) Y RESPUESTA EN LAS ESCALAS ESPECÍFICAS EN PACIENTES CON MIASTENIA GRAVIS GENERALIZADA (MGG) CON ANTICUERPOS ANTI-ACHR (ACHR+) EN ADAPT/ADAPT+
6. Aerobic training in persons who have recovered from juvenile dermatomyositis
7. Muscle regeneration in mitochondrial myopathies
8. Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study
9. EPH185 Healthcare Resource Utilization and Cost Burden Assessment of Patients with Myasthenia Gravis in Denmark, Finland, and Sweden
10. EE196 Real World Evidence on the Burden of Disease for Patients and Their Nearest Relatives - the Case of Duchenne Muscular Dystrophy
11. P359 12-minutes walking test in mitochondrial myopathy: a potential screening test
12. P352 FDG PET/CT in multiple acyl-CoA dehydrogenase deficiency late-onset: a case report
13. P348 Fatigue and associated factors in 172 patients with McArdle disease: an international web-based survey
14. P347 Toward an understanding of GSD5 (McArdle disease): How do patients learn to live with the metabolic defect in daily life?
15. P345 Development of continuum of care for McArdle disease (GDSV): a practical tool for clinicians and patients
16. P275 Response to rozanolixizumab in patients with generalized myasthenia gravis (gMG) from the Phase 3 MycarinG study
17. P97 Exploring the repeated bout effect in neuromuscular diseases
18. P424 Identify genetic modifiers controlling severity of collagen-6 related dystrophies (COL6-RD)
19. P386 Molecular biomarkers in myotonic dystrophy type 1
20. P283 Natural history of limb girdle muscular dystrophy R9: one-year follow-up of a European cohort
21. P281 Quality of life in adults with dysferlinopathy: international clinical outcome study of dysferlinopathy
22. P208 Paracetamol treatment in patients with spinal muscular atrophy: a different pharmacokinetic profile
23. P133 Influence of X-chromosome activation pattern in muscles on symptoms and progression of cardiac and muscle symptoms signs in women with pathogenic dystrophin gene variants: a 6-year follow-up of 53 patients
24. P120 Refining MRI pattern in sarcoglycanopathies: upper body pattern and new approaches to assess disease progression
25. P365 Cycle exercise in wheelchair users with muscular dystrophy
26. P364 Fat and glucose metabolism during exercise in patients with methylmalonic and propionic acidemia
27. P361 Acylcarnitine profiles in patients with mitochondrial myopathy under different physiological conditions
28. 144th ENMC International Workshop: Outcome Measures in McArdle Disease, 29 September–1 November 2006, Naarden, The Netherlands
29. P.175 Global FKRP registry - the research database for limb girdle muscular dystrophy R9 (2I)
30. P.173 Preliminary natural history quantitative MRI data in lower limb muscle and heart of patients with limb-girdle muscular dystrophy type R9
31. P.141 Manoeuvre study design: A study of GYM329 (RO7204239) in patients with facioscapulohumeral muscular dystrophy (FSHD)
32. P.136 Design of Reach: Phase 3 randomized, double-blind, placebo-controlled, 48-week study of the efficacy and safety of losmapimod in FSHD
33. P.96 Clinical characteristics of patients with seronegative myasthenia gravis
34. P.97 Clinical differences between ocular and generalized myasthenia gravis
35. P.81 Nutritional status and bone health in pediatric patients with low skeletal muscle mass
36. FP.19 Quantification of glycogen distribution in late-onset Pompe patients using 7 Tesla C13 NMR spectroscopy
37. P.74 Using high-field magnetic resonance spectroscopy to measure muscle glycogen in patients with McArdle disease
38. FP.18 Modified ketogenic diet in patients with McArdle disease: A double-blind, placebo-controlled, cross-over study
39. FP.06 Use of an exercise challenge system to define a universal proteomic signature of muscle injury in a diverse set of adults with inherited myopathy
40. P.06 Investigating the effect of a home-based training program on oxidative capacity in patients with truncating genetic variants in titin
41. P.03 Myosin dysregulation in nemaline myopathy
42. OTHER NMDs: EP.356 The phenotypic heterogeneity of autosomal recessive desmin myopathies
43. IMAGING: EP.332 Patients with McArdle disease have increased fat replacement of paraspinal muscles on MRI: a European multicenter study
44. SMA - TREATMENT: EP.275 Pharmacokinetics and safety of treatment with paracetamol in children and adults with spinal muscular atrophy
45. CHANNELOPATHIES AND RELATED DISORDERS: EP.226 Muscle fat fraction, cross-sectional area and contractility in patient with skeletal muscle sodium channel disorders
46. MITOCHONDRIAL DISEASES: EP.213 Plasma lactate responses during and after submaximal handgrip exercise are not diagnostically helpful in mitochondrial myopathy
47. METABOLIC MYOPATHIES: EP.206 No effect of oral ketone ester supplementation on exercise capacity in patients with McArdle disease: a randomized placebo-controlled cross-over study
48. METABOLIC MYOPATHIES: EP.204 No effect of resveratrol on exercise capacity in patients with fatty acid oxidation disorders
49. LGMD: EP.188 Elevation of fast but not slow muscle fiber injury biomarkers after exercise in Becker and LGMDR9 muscular dystrophies
50. LGMD: EP.178 Global FKRP Registry - the research database for limb girdle muscular dystrophy R9 (2I)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.